Semaglutide 10mg 5 Vials: GLP-1 Research Peptide

Third-Party Tested

Research Use Disclaimer:

All peptides offered by Prime Peptides are strictly intended for laboratory research purposes only. These products are not approved for human consumption, medical use, therapeutic applications, or diagnostic procedures. By purchasing or accessing information on this site, you acknowledge that it is your responsibility to comply with all applicable local, provincial/state, and federal laws and regulations regarding the handling, use, and storage of research chemicals and peptides. Prime Peptides assumes no liability for misuse, improper handling, or application of any products.

✓ In stock – Ships same day

SSL Secured Secure Checkout Guaranteed Delivery Third-Party Tested

Semaglutide is a synthetic research peptide belonging to the GLP-1 (glucagon-like peptide-1) receptor agonist class. It is widely studied for its effects on glucose regulation, metabolic signaling, gastric emptying, and energy balance in preclinical and in-vitro research models.

Designed with enhanced stability and a prolonged half-life, Semaglutide is an advanced tool for studying incretin-based metabolic pathways.

Scientific Background

Semaglutide is an analog of the native GLP-1 hormone, engineered to resist enzymatic breakdown and maintain prolonged receptor activation. In experimental systems, GLP-1 receptor activation is known to influence:

Insulin sensitivity
Glucose uptake
Appetite-regulation pathways
Gastric emptying speed
Energy metabolism

By modifying the native GLP-1 structure, Semaglutide displays significantly higher stability and receptor affinity compared to earlier incretin analogues.

Research Areas of Interest

All information below is strictly for laboratory, scientific, and in-vitro research discussion only.

1. Glucose Regulation Pathways

Semaglutide is widely used in research models to study:

Glucose homeostasis
Insulin modulation
Pancreatic β-cell signaling

2. Metabolic & Endocrine Research

Its GLP-1 receptor activity makes it valuable for investigating:

Metabolic rate changes
Appetite signaling
Hormonal crosstalk in metabolic tissues

3. Gastrointestinal Function Models

Research also explores potential roles in:

Gastric emptying
Gut-brain communication
Intestinal hormone signaling

4. Energy Balance & Weight-Regulation Systems

Preclinical models evaluate Semaglutide’s impact on:

Energy expenditure
Central appetite-regulation pathways
Caloric intake modulation

5. Comparison to Other Incretin Pathways

Semaglutide is frequently studied alongside:

Tirzepatide (GLP-1/GIP dual agonist)
Retatrutide (GLP-1/GIP/Glucagon triple agonist)
Liraglutide (earlier GLP-1 analog)

This allows researchers to evaluate differences in potency, stability, and receptor engagement.

Molecular Profile

Peptide: Semaglutide
Type: GLP-1 Receptor Agonist
Sequence Length: 31 amino acids (synthetic analogue with modifications)
Form: Lyophilized powder
Purity: ≥ 98% (HPLC tested)

Semaglutide includes proprietary fatty-acid and amino-acid modifications to extend half-life and is not typically displayed as a full open-source sequence by peptide suppliers.

Storage & Stability

Store lyophilized peptide at –20°C
Protect from heat, moisture, and light
Use reconstituted material promptly or store following laboratory protocol
Avoid repeated freeze-thaw cycles

Each 3ml vial is formulated with 10mg of highly purified (>99%) lyophilized Semaglutide, produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs.